DXN IPO oversubscribed 3.2 times
KUALA LUMPUR: DXN Holdings Bhd's initial public offering (IPO) was oversubscribed by 3.2 times by the Malaysian public, ahead of its return to the Main Market of Bursa Malaysia on May 19.
Stay updated with breaking news from Adxn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
KUALA LUMPUR: DXN Holdings Bhd's initial public offering (IPO) was oversubscribed by 3.2 times by the Malaysian public, ahead of its return to the Main Market of Bursa Malaysia on May 19.
DXN Holdings Bhd, en route to a listing on the Main Market of Bursa Malaysia, is expected to see significant improvement in its revenue for the financial year 2023 (FY23).
Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 223,100 shares, an increase of 195.9% from the March 31st total of 75,400 shares. Based on an average daily trading volume, of 430,900 shares, […]
Susquehanna International Group LLP purchased a new position in Addex Therapeutics Ltd (NASDAQ:ADXN – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 72,142 shares of the company’s stock, valued at approximately $45,000. Susquehanna International Group LLP owned 0.56% of Addex […]
KUALA LUMPUR: Main Market-bound DXN Holdings Bhd aims to raise about RM121.6mil from the public issue portion of its initial public offering (IPO), which will go towards the repayment of bank borrowings and working capital requirements.